Technical Analysis for NVTA - Invitae Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
17.43 | -1.02% | -0.18 |
NVTA closed down 1.02 percent on Friday, May 24, 2019, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| See historical NVTA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -1.02% | |
| Oversold Stochastic | Weakness | -1.02% | |
| 180 Bearish Setup | Bearish Swing Setup | -3.27% | |
| Wide Bands | Range Expansion | -3.27% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2019
- Sector: Healthcare
- Industry: Diagnostics & Research
Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Medicine Cancer Biology Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Neurology Genetic Disorders Cardiovascular Disorders Genetic Disorder
Medicine Cancer Biology Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Neurology Genetic Disorders Cardiovascular Disorders Genetic Disorder
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more NVTA news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 26.77 |
| 52 Week Low | 7.08 |
| Average Volume | 1,783,074 |
| 200-Day Moving Average | 16.3151 |
| 50-Day Moving Average | 22.6568 |
| 20-Day Moving Average | 20.46 |
| 10-Day Moving Average | 18.139 |
| Average True Range | 1.182 |
| ADX | 31.06 |
| +DI | 12.5207 |
| -DI | 29.6784 |
| Chandelier Exit (Long, 3 ATRs ) | 21.884 |
| Chandelier Exit (Short, 3 ATRs ) | 20.776 |
| Upper Bollinger Band | 26.1339 |
| Lower Bollinger Band | 14.7861 |
| Percent B (%b) | 0.23 |
| BandWidth | 55.463343 |
| MACD Line | -1.5263 |
| MACD Signal Line | -1.2852 |
| MACD Histogram | -0.2411 |
| Fundamentals | Value |
|---|---|
| Market Cap | 758.98 Million |
| Num Shares | 43.5 Million |
| EPS | -2.73 |
| Price-to-Earnings (P/E) Ratio | -6.38 |
| Price-to-Sales | 9.34 |
| Price-to-Book | 5.59 |
| PEG Ratio | -0.46 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.24 | ||||
| Resistance 3 (R3) | 18.32 | 18.12 | 18.11 | ||
| Resistance 2 (R2) | 18.12 | 17.92 | 18.09 | 18.06 | |
| Resistance 1 (R1) | 17.78 | 17.79 | 17.68 | 17.70 | 18.01 |
| Pivot Point | 17.58 | 17.58 | 17.54 | 17.55 | 17.58 |
| Support 1 (S1) | 17.24 | 17.38 | 17.14 | 17.16 | 16.85 |
| Support 2 (S2) | 17.04 | 17.25 | 17.01 | 16.80 | |
| Support 3 (S3) | 16.70 | 17.04 | 16.76 | ||
| Support 4 (S4) | 16.62 |
